Juan Montoro Selected Research

Juan Montoro Research Topics

11	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2016
10	Infections 09/2022 - 11/2011
4	Virus Diseases (Viral Diseases) 12/2020 - 10/2019
3	Neoplasms (Cancer) 09/2022 - 01/2020
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2022 - 12/2015
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020 - 08/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 06/2014
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021 - 01/2019
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 12/2015
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2016
2	Pneumonia (Pneumonitis) 01/2020 - 01/2019
2	Human Influenza (Influenza) 01/2020 - 01/2019
2	Mycoses (Diseases, Fungus) 10/2019 - 04/2019
1	Hematologic Diseases (Blood Diseases) 09/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	COVID-19 01/2022
1	Breakthrough Infections 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Disease Progression 01/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2020
1	Coinfection 08/2018
1	Leukemia 06/2017
1	Central Nervous System Infections (Central Nervous System Infection) 01/2017
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2013
1	Bronchiolitis Obliterans Syndrome 09/2012
1	Polymyositis 09/2012

6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2016
4	Sirolimus (Rapamycin)FDA Link 01/2022 - 01/2020
4	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 11/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2022 - 10/2019
3	AntibodiesIBA 09/2022 - 01/2022
2	Monoclonal AntibodiesIBA 09/2022 - 12/2015
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 11/2020
2	Antiviral Agents (Antivirals)IBA 01/2020 - 11/2011
1	VaccinesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	NivolumabIBA 01/2021
1	Brentuximab VedotinIBA 01/2021
1	Prednisone (Sone)FDA LinkGeneric 12/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2020
1	Busulfan (Busulfex)FDA Link 01/2020
1	AntigensIBA 01/2020
1	fludarabineIBA 01/2020
1	Micafungin (FK463)FDA Link 08/2018
1	Voriconazole (Vfend)FDA LinkGeneric 08/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017
1	Rituximab (Mabthera)FDA Link 12/2015
1	Chlorambucil (Leukeran)FDA Link 12/2015
1	CD20 AntigensIBA 12/2015
1	pegfilgrastim (Neulasta)FDA Link 06/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2013
1	oxidized low density lipoproteinIBA 03/2013
1	HLA-DR Antigens (HLA-DR)IBA 09/2012

19	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2012
13	Stem Cell Transplantation 05/2022 - 11/2011
9	Therapeutics 09/2022 - 11/2011
8	Transplantation 12/2020 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2015
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Haploidentical Transplantation 11/2020
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2020
1	Homologous Transplantation 01/2016
1	Blood Component Removal (Apheresis) 03/2013